| The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation B Mathew, FE Lennon, J Siegler, T Mirzapoiazova, N Mambetsariev, ... Anesthesia & Analgesia 112 (3), 558-567, 2011 | 293 | 2011 |
| The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer FE Lennon, T Mirzapoiazova, B Mambetsariev, VA Poroyko, R Salgia, ... PloS one 9 (3), e91577, 2014 | 206 | 2014 |
| Hyaluronan regulation of vascular integrity FE Lennon, PA Singleton American journal of cardiovascular disease 1 (3), 200, 2011 | 198 | 2011 |
| Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea I Almendros, Y Wang, L Becker, FE Lennon, J Zheng, BR Coats, ... American journal of respiratory and critical care medicine 189 (5), 593-601, 2014 | 195 | 2014 |
| Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis FE Lennon, T Mirzapoiazova, B Mambetsariev, R Salgia, J Moss, ... The Journal of the American Society of Anesthesiologists 116 (4), 857-867, 2012 | 193 | 2012 |
| Lung cancer—a fractal viewpoint FE Lennon, GC Cianci, NA Cipriani, TA Hensing, HJ Zhang, CT Chen, ... Nature reviews Clinical oncology 12 (11), 664-675, 2015 | 185 | 2015 |
| The μ-opioid receptor in cancer progression: is there a direct effect? FE Lennon, J Moss, PA Singleton, B Riou The Journal of the American Society of Anesthesiologists 116 (4), 940-945, 2012 | 182 | 2012 |
| EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation L Faoro, PA Singleton, GM Cervantes, FE Lennon, NW Choong, R Kanteti, ... Journal of Biological Chemistry 285 (24), 18575-18585, 2010 | 139 | 2010 |
| Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology FE Lennon, PA Singleton American Journal of Physiology-Lung Cellular and Molecular Physiology 301 (2 …, 2011 | 135 | 2011 |
| FAK and paxillin, two potential targets in pancreatic cancer R Kanteti, SK Batra, FE Lennon, R Salgia Oncotarget 7 (21), 31586, 2016 | 119 | 2016 |
| High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness PA Singleton, T Mirzapoiazova, Y Guo, S Sammani, N Mambetsariev, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 299 (5 …, 2010 | 108 | 2010 |
| Hyaluronic acid binding protein 2 is a novel regulator of vascular integrity N Mambetsariev, T Mirzapoiazova, B Mambetsariev, S Sammani, ... Arteriosclerosis, thrombosis, and vascular biology 30 (3), 483-490, 2010 | 107 | 2010 |
| Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and cell proliferation in human vascular endothelial cells JF Murphy, F Lennon, C Steele, D Kelleher, D Fitzgerald, A Long The FASEB journal 19 (3), 1-17, 2005 | 98 | 2005 |
| MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma R Kanteti, I Dhanasingh, I Kawada, FE Lennon, Q Arif, R Bueno, R Hasina, ... PloS one 9 (9), e105919, 2014 | 67 | 2014 |
| Mitochondrial dynamics: biology and therapy in lung cancer FE Lennon, R Salgia Expert opinion on investigational drugs 23 (5), 675-692, 2014 | 58 | 2014 |
| Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer I Kawada, R Hasina, FE Lennon, VP Bindokas, P Usatyuk, YHC Tan, ... Cancer biology & therapy 14 (7), 679-691, 2013 | 45 | 2013 |
| Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma FE Lennon, GC Cianci, R Kanteti, JJ Riehm, Q Arif, VA Poroyko, ... Scientific reports 6 (1), 24578, 2016 | 43 | 2016 |
| Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression FE Lennon, T Mirzapoiazova, N Mambetsariev, B Mambetsariev, R Salgia, ... Journal of Biological Chemistry 289 (35), 24043-24058, 2014 | 42 | 2014 |
| Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors PA Singleton, N Mambetsariev, FE Lennon, B Mathew, JH Siegler, ... Journal of angiogenesis research 2, 1-14, 2010 | 38 | 2010 |
| HABP2 is a novel regulator of hyaluronan-mediated human lung cancer progression T Mirzapoiazova, N Mambetsariev, FE Lennon, B Mambetsariev, ... Frontiers in oncology 5, 164, 2015 | 37 | 2015 |
